Quick Answer
Solriamfetol is legal in Japan but not classified as a controlled substance, meaning it is not scheduled under narcotics or stimulant control laws. However, it is strictly prescription-only, and access is regulated through Japan’s pharmaceutical system. Possession is generally allowed with a valid prescription, while importation and online purchasing are subject to oversight and may be limited.
Drug Overview
- Generic name: Solriamfetol
- Brand names: Sunosi
- Drug class: Dopamine and norepinephrine reuptake inhibitor (DNRI)
- Common uses:
- Treatment of excessive daytime sleepiness associated with narcolepsy
- Management of sleepiness in obstructive sleep apnea (OSA)
Solriamfetol is a relatively newer wakefulness-promoting agent, developed as an alternative to older stimulants. Unlike traditional amphetamines, it has a distinct pharmacological profile, which influences how it is regulated in different countries.
Legal and Controlled Status in Japan
Is it a controlled substance?
In Japan, solriamfetol is not listed as a controlled substance under major drug control laws such as the Narcotics and Psychotropics Control Act or the Stimulants Control Act. These laws typically govern substances with high abuse potential, such as amphetamines or certain sedatives.
Because solriamfetol does not fall into these categories, it is not considered a controlled drug in the Japanese legal framework. This distinguishes it from medications like modafinil (which has faced tighter scrutiny in some jurisdictions) or amphetamine-based treatments.
Is it legal?
Yes, solriamfetol is legal in Japan, but only within the framework of approved medical use. Like many modern prescription medications, it is regulated under Japan’s Pharmaceutical and Medical Device Act (PMD Act).
This means:
- It can be prescribed by licensed physicians
- It must be dispensed through authorized pharmacies
- It cannot be freely sold or distributed outside regulated channels
Is a prescription required?
Yes. Solriamfetol is prescription-only in Japan.
Patients must:
- Receive a diagnosis from a licensed healthcare provider
- Obtain a prescription
- Purchase the medication from a registered pharmacy
It is not available over the counter, and pharmacists cannot dispense it without proper documentation.
Possession and Use
In practical terms, possession of solriamfetol in Japan is generally allowed when supported by a valid prescription.
For patients:
- Carrying a prescribed quantity for personal use is typically acceptable
- Use must align with the prescribed treatment plan
Without a prescription:
- Possession may be considered non-compliant with pharmaceutical regulations
- Authorities may treat such cases as improper handling of prescription medicine
However, since solriamfetol is not a controlled substance, the regulatory approach is typically less strict than for narcotics or stimulants. The emphasis is on proper medical authorization rather than criminal classification.
Buying Online
Purchasing solriamfetol online in Japan involves several considerations.
Key points:
- Prescription requirement still applies – even for online purchases
- Only licensed Japanese online pharmacies may legally dispense prescription drugs
- Foreign websites may not comply with Japanese regulations
In practice:
- Orders from overseas pharmacies may be subject to customs review
- Shipments without proper documentation may not be delivered
- Product authenticity and storage conditions can vary
Because of these factors, obtaining solriamfetol through local, regulated channels is generally the most reliable option.
Import Rules
Japan allows limited personal importation of medications, but this process is regulated.
General principles:
- Small quantities for personal use may be allowed
- A valid prescription or doctor’s letter is often required
- Importation may require a Yakkan Shoumei (import certificate) depending on quantity and drug type
Since solriamfetol is not controlled:
- It is not automatically prohibited, but still subject to pharmaceutical import rules
- Customs authorities may review shipments on a case-by-case basis
Travelers bringing solriamfetol into Japan should:
- Carry documentation
- Keep quantities consistent with personal use
- Be prepared for inspection
Rules may vary depending on circumstances, including dosage and duration of stay.
Penalties and Risks
Non-compliance with Japan’s pharmaceutical regulations typically results in administrative actions rather than criminal penalties, especially for non-controlled drugs.
Possible outcomes include:
- Shipments being held or returned by customs
- Medication being confiscated if documentation is insufficient
- Requests for additional paperwork
Because solriamfetol is not a controlled substance, enforcement tends to focus on regulatory compliance rather than criminal classification.
Official Classification Summary
- Controlled substance: No
- Schedule / classification: Not scheduled under narcotics or stimulant laws
- Prescription required: Yes
- Over-the-counter: No
- Personal importation: Restricted (allowed under conditions)
- Regulatory authority: Ministry of Health, Labour and Welfare (MHLW)
- Relevant law or act: Pharmaceutical and Medical Device Act (PMD Act)
- Last reviewed: April 2026
What This Means in Practice
For residents of Japan:
- Solriamfetol is accessed through standard medical channels
- A doctor’s consultation is required before obtaining it
- Pharmacies dispense it under prescription control
For travelers:
- Bringing solriamfetol into Japan is generally possible with documentation
- Quantities should reflect personal use
- Customs procedures may apply
Importantly, even though solriamfetol is not controlled, it is still regulated. This means:
- “Not controlled” does not equal unrestricted access
- Prescription requirements remain strictly enforced
Brand Names and Local Availability
The primary brand name for solriamfetol is Sunosi.
Availability in Japan may be:
- Limited compared to older wakefulness agents
- Dependent on regulatory approval and prescribing practices
In some cases, physicians may:
- Prefer alternative medications with longer availability history
- Prescribe solriamfetol selectively based on patient profile
For reference, the European regulatory documentation for solriamfetol confirms its prescription-only status, as outlined in the European Medicines Agency Sunosi EPAR overview.
Special Notes
Regulatory nuance
Japan’s regulatory system distinguishes clearly between:
- Controlled substances (strictly scheduled)
- Prescription medicines (medically regulated but not scheduled)
Solriamfetol falls into the second category.
Customs discretion
Even when rules allow importation:
- Customs officers retain discretion
- Documentation quality can influence outcomes
Prescription practices
Japanese physicians may:
- Require thorough diagnostic confirmation
- Monitor use closely due to the drug’s stimulating effects
Additional Insights
Comparison with Similar Drugs
Solriamfetol differs from traditional stimulants like amphetamines, which are tightly controlled in Japan. It also differs from modafinil, which has faced regulatory scrutiny due to misuse potential.
This difference explains why solriamfetol is:
- Not controlled, but
- Still prescription-restricted
Formulation and Dosing Considerations
Solriamfetol is typically available as oral tablets in fixed strengths. The simplicity of its formulation contributes to:
- Easier prescribing
- Lower regulatory complexity compared to multi-form stimulant drugs
International Regulatory Context
Globally, solriamfetol’s classification varies. For example, clinical and regulatory information provided in the Sunosi FDA prescribing information shows that while it is regulated, it is not treated identically to classic stimulants.
Japan’s approach aligns with this trend:
- Recognizing medical use
- Avoiding strict controlled classification
FAQ
Is solriamfetol legal in Japan?
Yes, solriamfetol is legal in Japan, but it is only available with a valid prescription and must be obtained through authorized medical channels.
Is solriamfetol a controlled substance in Japan?
No, solriamfetol is not classified as a controlled substance under Japanese drug control laws.
Do you need a prescription for solriamfetol in Japan?
Yes, a prescription from a licensed physician is required to legally obtain and use solriamfetol.
Can you import solriamfetol into Japan?
Personal importation may be allowed in limited quantities with proper documentation, but shipments are subject to review and may require approval.
Is it legal to buy solriamfetol online in Japan?
Buying online is only legal if the pharmacy is licensed and a valid prescription is provided. Overseas purchases may face delivery or compliance issues.
Safety Disclaimer
This content is for informational purposes only and does not constitute medical advice.
Leave a Reply